Albumin, hemoglobin, hypertrophy of left ventricular heart and quality of life in patients on renal replacement therapy
https://doi.org/10.26295/OS.2021.59.57.008
Abstract
Left ventricular hypertrophy, hypoalbuminemia, and anemia are the risk factors for cardiovascular complications in patients with CKD 5. In addition, mortality from cardiovascular complications depends on the quality of life. In this regard, the purpose of this study was to study the structural parameters of the heart, hemoglobin and albumin levels in patients with CKD 5 on renal replacement therapy, depending on the quality of life indicators according to the SF-36 questionnaire. 65 patients on hemodialysis, peritoneal dialysis, and kidney transplant recipients were examined. Patients did not have clinical and laboratory signs of protein-energy insufficiency, blood hemoglobin was at least 100 g/l. All patients underwent general and biochemical blood tests, echocardiography, and SF-36 questionnaire. It has been shown that patients with CKD 5 on renal replacement therapy, with quality of life indicators below 50 points on the SF-36 scale, are more likely to have left ventricular myocardial hypertrophy, lower blood albumin and hemoglobin values.
About the Authors
S. E. Urazlina
Ural State Medical University
Россия
Россия
Ekaterinburg
T. V. Zhdanova
Ural State Medical University
Россия
Россия
Ekaterinburg
A. V. Nazarov
Ural State Medical University
Россия
Россия
Ekaterinburg
T. V. Zueva
Ural State Medical University
Россия
Россия
Ekaterinburg
References
1. Liebman S., Li N. C., Lacson E. Change in quality of life and one-year mortality risk in maintenance dialysis patients // Qual Life Res. 2016. V. 25. № 9. Р. 2295- 2306. DOI: 10.1007/s11136-016-1257-y.
2. Trajceska L., Mladenovska D., Dzekova-Vidimliski P. et al.Quality of LifeRepeated Measurements Are Needed In Dialysis Patients // Open Access Maced J Med Sci. 2018. V. 6. № 8. P. 1410-1412. DOI: 10.3889/oamjms.2018.305.
3. Perl J., Karaboyas A., Morgenstern H. et al. Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS // Nephrol Dial Transplant. 2017. V. 32. № 3. P. 521-527. DOI: 10.1093/ndt/gfw233.
4. Dobronravov V. A., Vasilieva I. A., Babarykina E. V. Kachestvo zhizni I otdalennaya serdechno-sosudistaya vyzhivaemost bolnykh na gemodialize [Quality of life and long-term cardiovascular survival of patients on hemodialysis] // Nefrologiya. 2016. V. 20. № 3. P. 78-84 (in Russ.).
5. Zueva T. V., Zhdanova T. V., Uraslina S. E. Komorbidnost pochechnoi i kardialnoi patologii [Comorbidity of renal and cardiac pathology] // Meditsinski vestnik Severnogo Kavkaza. 2019. V. 14. № 4. P. 711-717. DOI: https://doi.org/10.14300/mnnc.2019.14178 (in Russ.).
6. Major R. W., Cheng M., Grant R. A. et al. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis // PLoS One. 2018. 21; 13 (3): e0192895. DOI: 10.1371/journal.pone.0192895.
7. Wang A. Y., Sanderson J. E. Current perspectives on diagnosis of heart failure in long-term dialysis patients // Am J Kidney Dis. 2011. V. 57. № 2. P. 308-319. DOI: 10.1053/j.ajkd.2010.07.019.
8. Dubin R. F., Deo R., Bansal N. et al. Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort // Clin J Am Soc Nephrol. 2017. V. 12. № 1. P. 60-68. DOI: 10.2215/CJN.02700316.
9. Urazlina S. E., Zhdanova T. V., Zueva T. V. et al. Heart remodeling and quality of life in patients with chronic kidney disease on renal replacement therapy // Medical News of North Caucasus. 2019. V. 14. № 3. P. 453-457. DOI: https://doi.org/10.14300/mnnc.2019.14109.
10. Ellouali F., Berkchi F., Bayahia R. et al. Comparison of the Effects of Dialysis Methods (Haemodialysis vs Peritoneal Dialysis) on Diastolic Left Ventricular Function Dialysis Methods and Diastolic Function // Open Cardiovasc Med J. 2016. № 10. P. 171-178. DOI: 10.2174/1874192401610010171.
11. Slubowska K., Lichodziejewska B., Pruszczyk P. et al. Left ventricular hypertrophy in renal transplant recipients in the first year after transplantation // Transplant Proc. 2014. V. 46. № 8. P. 2719-2723. DOI: 10.1016/j.transproceed.2014.08.019.
12. Ryu S. R., Park S. K., Jung J. Y. et al. The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) // J Korean Med Sci. 2017. V. 32. № 2. P. 249-256. DOI: 10.3346/jkms.2017.32.2.249.
Review
For citations:
Urazlina S.E., Zhdanova T.V., Nazarov A.V., Zueva T.V. Albumin, hemoglobin, hypertrophy of left ventricular heart and quality of life in patients on renal replacement therapy. Lechaschi Vrach. 2021;(1):38-40. (In Russ.) https://doi.org/10.26295/OS.2021.59.57.008
Views:
200
JATS XML
Email this article 
